Dr. Ali Es’haghi, Director of the Razi Institute, saw the move as an important step in developing international cooperation and expanding the Razi Institute’s export market.
He stressed that the world is lacking inactivated polio vaccines (IPVs), and countries such as Venezuela are facing further restrictions due to international sanctions.
He added that following official requests from the Venezuelan government and a visit to the Raj Institute by a high-ranking delegation of the country, a formal agreement has been reached to supply oral polio vaccines.
“Under this agreement, the Razi Institute has taken action to leverage its technical capabilities and production capacity and produce it to produce, prepare and transfer the shipment of oral polio vaccines to this Latin American country,” stressed Es’haghi.
He emphasized that the Institute has strict adherence to technical standards and international transport protocols throughout the process.
The vaccine was transported under carefully controlled conditions, and all procedures were introduced to store the cold chain at -20°C to ensure effectiveness during shipment, he continued.
The cargo was sent directly from Tehran to Caracas, he said, adding that the initiative highlights Iran’s commitment to global health.
Es’haghi noted that vaccine delivery is not only a response to the need for a friendly nation in critical health situations, but also opened a new chapter in the Razi Institute’s export to South America.
He further expressed hope that the move would pave the way for a more effective presence of the institute’s products in Latin America, Eurasia, Africa and its neighbouring countries.
MA/ISN1404031006063